Clinical Trials Directory

Trials / Completed

CompletedNCT02445378

Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy

The Effect of Aromatherapy on Insomnia and Other Common Cancer Patient Symptoms

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This randomized clinical trial studies aromatherapy and essential oils in improving insomnia and other symptoms in patients with newly diagnosed acute leukemia. Aromatherapy and essential oils may help improve insomnia and other complications caused by chemotherapy.

Detailed description

PRIMARY OBJECTIVES: I. Does the addition of aromatherapy by diffusion of essential oils improve insomnia in newly diagnosed, hospitalized leukemia patients? SECONDARY OBJECTIVES: I. Does the addition of aromatherapy by diffusion of essential oils improve other common symptoms in newly diagnosed, hospitalized leukemia patients, including pain, nausea, lack of appetite, shortness of breath, depression, anxiety and wellbeing? II. Do newly diagnosed, hospitalized leukemia patients find the use of aromatherapy for symptom management a positive experience? OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Patients select between 3 scented essential oils: peppermint, lavender, or chamomile which is diffused in the hospital room from approximately 9 PM in the evening until morning during week 1 and placebo intervention using rose water during week 2. GROUP II: Patients undergo placebo intervention using rose water during week 1 and aromatherapy and essential oils as in Group I during week 2.

Conditions

Interventions

TypeNameDescription
PROCEDUREAromatherapy and Essential OilsUndergo aromatherapy and essential oils
OTHERPlaceboUndergo placebo intervention using rose water
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2014-12-28
Primary completion
2016-09-01
Completion
2016-11-05
First posted
2015-05-15
Last updated
2019-04-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02445378. Inclusion in this directory is not an endorsement.